| Factor Information | |
|---|---|
| Data ID | 3768 |
| Factor | Gestational age at birth(week) |
| Description | N/A |
| Biomarker | NA |
| Classification | E3 (physiological factor - birth age) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | To determine risk factors for NEC in patients with CHD |
| p Value | <0.05 |
| Conclusion | In the case–control analysis, earlier gestational age at birth , prematurity, highest dose of prostaglandin >0.05 g/kg/minute and episodes of low cardiac output (meeting specific laboratory criteria) or clinical shock correlated with the development of NEC. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 703 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
| Reference | |
|---|---|
| PMID | 11061778 |
| Year | 2000 |
| Title | Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | patients | |
| Region | Pennsylvania, Philadelphia | |
| Method | multivariable logistic regression | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | Surgical or transcatheter treatment | |
| Group | NEC group(Treatment) | control group(Control) |
| Number | 21 | 70 |
| Age | 5.1± 6.4 days | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 36.7±2.7 | 38.1±2.3 |
